Search results for " QbD"
								 					Article
				
				Early Communication with Regulators is Essential for SMEs
								With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process.
	…								
								 					Article
				
				2014 Manufacturing Trends and Outlook
								However, almost 32% of the respondents have not implemented QbD. Reasons cited for not implementing QbD include a lack of guidance and direction from regulatory agencies (46.2%), no process or quality…								
								 					Article
				
				Essentials in Establishing and Using Design Space
								Knowledge of product or process acceptance criterion is crucial in design space.  
	
	
		Design space is generally considered to be the areas where the product or process parameters can be run safe…								
								 					Article
				
				A Platform Approach for the Purification of Domain Antibodies (Dabs)
								This Application note describes a three-step purification process of a domain antibody (Dab) expressed in the periplasm of E. coli. First, a capture step using Capto™ L was used to reduce E. coli host…								
								 					Article
				
				Filtration methods to overcome new challenges in viral safety
								
	
	
	Read our article which summarizes the recent virus filtration regulatory changes in PDA Technical Report No. 41 and ICH Q5A, and outlines the detailed mechanisms governing effective virus filt…								
								 					Article
				
				Getting your investigational drug regulatory ready
								
	
	
	Navigating regulatory requirements can be an overwhelming and time-consuming part of the translational journey. From the submission of an investigational new drug (IND) application, regulators…								
								 					Article
				
				Digitalization: The Route to Biopharma 4.0
								In a case study, it was seen that integrating a distributed control system with the sensors and control elements provided a means to implement QbD and PAT in continuous manufacturing (12). In addition…								
								 					Article
				
				Host cell protein quantitation using ELISA
								
	
	
	
Host cell proteins (HCPs) produced by cells during biologic manufacturing must be removed from the final product to protect patients. However, it’s challenging to detect HCP, and this step c…								
								 					Article
				
				eBook: Purification of Antibody Therapeutics - Approach for Diversified Pipeline
								
	
	
	Antibody therapeutics are the largest class of biotherapeutics. Over the years, development beyond traditional monoclonal antibodies (mAbs) has increased. Today, we see multispecific and bispe…								
								 					Article
				
				Top Process Development Trends for 2021 and a Look into 2022
								
	The COVID-19 pandemic continues to shape bioprocess development trends, and many lessons have been learned from industry’s response to and preparedness for dealing with a public health crisis. Howev…